Study guide
Postoperative inflammation, haemorrhage and PCO
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Postoperative inflammation, haemorrhage and PCO
Key Takeaways Explain This Topic AI
TASS and infection can overlap in presentation, so timing and a clear vitreous alone cannot exclude infection.
Suprachoroidal haemorrhage requires stabilization and individualized assessment rather than a fixed drainage delay.
Before YAG treatment, confirm PCO explains the symptoms and consider retinal, pressure and implant risks.
Last updated: October 2026
- Dropped Nucleus & Suprachoroidal Haemorrhage
- The Dropped Nucleus Protocol
If a hard nuclear fragment drops through a capsular tear into the mid- or posterior vitreous cavity: NEVER chase the fragment into the vitreous with the phaco tip or vitrectomy cutter .
Blind posterior manipulation with non-vitreoretinal instruments causes giant retinal tears, rhegmatogenous retinal detachment, and catastrophic choroidal bleeding.
Management: Perform a meticulous bimanual anterior vitrectomy to ensure the anterior chamber and corneal incisions are completely free of vitreous. Implant a sulcus IOL if capsular rim support permits, or leave the eye aphakic. Suture all incisions securely with 10 − 0 10-0 10 − 0 nylon. Refer the patient urgently to a vitreoretinal surgeon for elective three-port 23 G / 25 G 23\text{G}/25\text{G} 23 G /25 G pars plana vitrectomy with phacofragmatome at timing determined by fragment size, inflammation, pressure, corneal clarity and retinal findings.
Acute Suprachoroidal Haemorrhage
Etiology: Rupture of a posterior or long ciliary artery into the suprachoroidal potential space between the choroid and sclera, driven by acute intraoperative hypotony in eyes with arteriosclerosis, systemic hypertension, advanced age, glaucoma, or high myopia.
Clinical Presentation: Sudden, rock-hard globe; abrupt shallowing of the anterior chamber; extrusion of the iris and intraocular contents through the wound; dark brown choroidal elevations visible in the pupil; and immediate loss of the red reflex.
Emergency Surgical Management:
Immediate Wound Closure: Abandon intraocular maneuvers instantly. Close all clear corneal and paracentesis incisions with pre-placed sutures or digital compression. Re-establishing intraocular pressure tamponades the bleeding artery.
Medical Tamponade: Administer IV mannitol ( 1.0 − 2.0 g/kg 1.0-2.0\text{ g/kg} 1.0 − 2.0 g/kg ), systemic antihypertensives, and high-dose intravenous/oral corticosteroids.
Further assessment and drainage: Close and stabilize the eye, then assess the extent with vitreoretinal input and ultrasound. Drainage may be timed to clot liquefaction, but apposition, pain, pressure, retinal involvement and the clinical course determine timing; a fixed 10–14-day delay is not mandatory in every threatened eye.
Toxic Anterior Segment Syndrome (TASS) vs Acute Postoperative Endophthalmitis
Distinguishing between sterile Toxic Anterior Segment Syndrome (TASS) and acute microbial endophthalmitis is one of the most critical clinical differentials in ophthalmology:
Diagnostic Feature Toxic Anterior Segment Syndrome (TASS) Acute Infectious Endophthalmitis
Onset of Presentation Hyperacute: 12 to 24 hours postoperatively (rarely up to 48 hours). Subacute / Delayed: 3 to 7 days postoperatively (median day 4–5).
Etiological Mechanism Sterile, non-infectious toxic/chemical insult to anterior segment structures. True intraocular microbial replication and active bacterial proliferation.
Common Causative Agents Bacterial endotoxins in autoclave steam; enzymatic detergent residues on cannulas; denatured OVD; intraocular preservatives (BAK); chlorhexidine; non-isotonic BSS. Staphylococcus epidermidis (coagulase-negative, ∼ 70 % \sim 70\% ∼ 70% ); Staphylococcus aureus ( ∼ 10 % \sim 10\% ∼ 10% ); Streptococcus species ( ∼ 10 % \sim 10\% ∼ 10% ); Gram-negative bacilli ( Pseudomonas , ∼ 5 % \sim 5\% ∼ 5% ).
Ocular Pain Mild discomfort or completely painless. Severe, deep, throbbing, unrelenting pain (marked in > 75 % >75\% > 75% of patients).
Corneal Findings Diffuse, limbus-to-limbus corneal oedema (widespread toxic endothelial necrosis). Focal wound oedema; central cornea frequently remains clear early in disease.
Anterior Chamber Heavy fibrinous reaction, large hypopyon, trabecular outflow shutdown with elevated IOP. Heavy fibrinous exudate, hypopyon, marked cellular reaction.
Pupil / Iris Fixed, dilated, or irregular pupil; iris atrophy (toxic sphincter necrosis). Pupil reactive or sluggish; no primary pupillary paralysis.
Vitreous and red reflex Usually predominantly anterior inflammation without substantial vitritis; view may still be reduced by corneal oedema Vitritis often occurs, but early or atypical infection may not have a completely absent red reflex
Response to Therapy Dramatic, rapid resolution with intensive topical corticosteroids (e.g., prednisolone acetate 1 % 1\% 1% hourly). Progressive deterioration without intravitreal antibiotics; steroids alone worsen condition.
Acute Postoperative Endophthalmitis: Prevention and Initial Response
Use ocular-surface antisepsis with an appropriate povidone-iodine preparation and validated intracameral antibiotic prophylaxis according to local guidance. Allergy, concentration, contamination and dilution errors matter; prophylaxis must not replace aseptic technique.
Suspected infection requires urgent vitreoretinal assessment, sampling and intravitreal antibiotics. Common empiric coverage is vancomycin 1 mg/0.1 mL plus ceftazidime 2.25 mg/0.1 mL using separately prepared validated syringes. Confirm allergy and local protocol; intravitreal steroid adjuncts have uncertain benefit.
The 1995 Endophthalmitis Vitrectomy Study (EVS) involved acute postoperative infection after cataract or secondary-IOL surgery. Immediate vitrectomy improved outcomes in its light-perception-only subgroup, while tap/inject and vitrectomy had similar outcomes for better initial acuity. Modern surgical systems and different infections require individual decisions: hand-motions acuity does not preclude vitrectomy, and the study cannot be applied unchanged to traumatic, endogenous or fungal disease. Treatment is urgent and cannot await cultures.
TASS and infection overlap in onset, pain and inflammatory signs. A clear vitreous with early diffuse corneal oedema supports TASS, but uncertainty requires assessment and treatment for possible infection rather than an unobserved steroid trial.
Posterior Capsule Opacification (PCO) & Nd:YAG Laser Capsulotomy
Posterior capsule opacification is the most common delayed complication of modern cataract surgery, developing in 20 to 40 % 20\text{ to }40\% 20 to 40% of eyes within 2 to 5 years.
Pathogenesis & Morphological Forms
Residual equatorial lens epithelial cells (LECs) survive surgical aspiration, proliferate, migrate across the posterior capsule, and undergo epithelial-mesenchymal transition (EMT):
Regeneratory / Pearl-Type PCO: Proliferating epithelial cells swell into large, clusters of globular, nucleated cells: Elschnig pearls (histologically identical to Wedl cells). This is the most common form, causing gradual reduction in visual acuity, contrast sensitivity, and photopic glare.
Fibrotic PCO: Myofibroblastic transdifferentiation produces alpha-smooth muscle actin ( α \alpha α -SMA), causing capsular wrinkling, contracture, dense fibrosis, and star-shaped folds along the visual axis.
Preventive Surgical Factors
Square-Edge Optic Geometry: A sharp, 90 ∘ 90^\circ 9 0 ∘ posterior optic edge acts as a mechanical barrier that arrests migrating lens epithelial cells.
Complete 360 ∘ 360^\circ 36 0 ∘ Capsulorhexis Overlap: Ensuring the anterior rhexis leaf completely overlaps the 6.0 mm 6.0\text{ mm} 6.0 mm optic creates an anatomical shrink-wrap seal.
IOL Material: Hydrophobic acrylic polymers bind fibronectin tightly, establishing superior capsular adhesion and lower PCO rates than hydrophilic acrylic or PMMA.
Nd:YAG Laser Capsulotomy Technique & Complications
Laser Physics: Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) pulsed laser ( λ = 1064 nm \lambda = 1064\text{ nm} λ = 1064 nm , infrared). Operates by optical breakdown and photodisruption: intense localized electrical field ionizes tissue into plasma, producing acoustic shock waves that cut the non-pigmented capsule.
Technique: Use the device-specific focusing offset and the lowest effective pulse energy. Place an opening appropriate to visual symptoms, pupil size and IOL position while avoiding optic pitting. Energy, offset and aperture diameter are adjustable clinical choices, not fixed settings for every eye.
Complications:
Transient IOP Spike: Peaks at 1 to 4 hours post-laser due to trabecular meshwork clogging by capsular debris and inflammatory cells. Prophylaxis: topical apraclonidine 1 % 1\% 1% or brimonidine 0.2 % 0.2\% 0.2% before and after the procedure.
IOL Pitting / Damage: Optical divots created if the laser is focused directly on the IOL material.
Macular oedema: Investigate reduced vision with examination and OCT; risk depends on inflammation and retinal comorbidity.
Retinal tears/detachment: Counsel about new flashes, floaters and a curtain, especially with myopia or previous retinal disease. A fixed percentage increase does not apply to every capsulotomy.